INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Dec 16, 2016 |
Director, President and CSO
Trans History: 572
|
Director, President and CSO | Bona fide gift | 89,427 | -- |
| Nov 22, 2016 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 59,788 | -- |
| Nov 15, 2016 |
Director
Trans History: 269
|
Director | Bona fide gift | 1,000 | -- |
| Nov 07, 2016 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Bona fide gift | 7,876 | -- |
| Oct 03, 2016 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 531 | -- |
| Jul 21, 2016 |
Director, President Regeneron Laboratori
Trans History: 572
|
Director, President Regeneron Laboratori | Bona fide gift | 500,000 | -- |
| Jul 21, 2016 |
Director, President Regeneron Laboratori
Trans History: 572
|
Director, President Regeneron Laboratori | Bona fide gift | 500,000 | -- |
| Jul 01, 2016 |
Director, Chairman of the Board
Trans History: 677
|
Director, Chairman of the Board | Bona fide gift | 608 | -- |
| May 24, 2016 |
Director
Trans History: 269
|
Director | Bona fide gift | 1,000 | -- |
| May 16, 2016 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Bona fide gift | 2,459 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.